Psychiatry research in the COVID-19 era and beyond: A role for mathematical models
Waters, Edward K, Pellen, Daniel, Buus, Niels
Published in Australian and New Zealand journal of psychiatry (01.02.2021)
Published in Australian and New Zealand journal of psychiatry (01.02.2021)
Get more information
Journal Article
Adjunctive canakinumab reduces peripheral inflammation markers and improves positive symptoms in people with schizophrenia and inflammation: A randomized control trial
Weickert, Thomas W., Jacomb, Isabella, Lenroot, Rhoshel, Lappin, Julia, Weinberg, Danielle, Brooks, William S., Brown, David, Pellen, Daniel, Kindler, Jochen, Mohan, Adith, Wakefield, Denis, Lloyd, Andrew R., Stanton, Clive, O'Donnell, Maryanne, Liu, Dennis, Galletly, Cherrie, Shannon Weickert, Cynthia
Published in Brain, behavior, and immunity (01.01.2024)
Published in Brain, behavior, and immunity (01.01.2024)
Get full text
Journal Article
A certificate in youth psychiatry: meeting the training needs of psychiatrists
Macmillan, Iain, Thompson, Andrew, Kalucy, Megan, Pellen, Daniel, Killackey, Eóin, McGorry, Patrick, Scott, James G
Published in Australasian psychiatry : bulletin of the Royal Australian and New Zealand College of Psychiatrists (01.02.2021)
Published in Australasian psychiatry : bulletin of the Royal Australian and New Zealand College of Psychiatrists (01.02.2021)
Get more information
Journal Article
The value of early intervention in creating the new mental health system: Response to Allison et al
Chanen, Andrew, Yung, Alison, Killackey, Eoin, Hickie, Ian, Coghill, David, Scott, James G, Scott, Elizabeth, Denborough, Paul, Dixon, Lisa, Fisher, Leeanne, Kane, John, Malla, Ashok, Nordentoft, Merete, Pellen, Daniel, Radovini, Alessandra, McGorry, Patrick
Published in Australian and New Zealand journal of psychiatry (01.07.2020)
Published in Australian and New Zealand journal of psychiatry (01.07.2020)
Get more information
Journal Article
107. Reduction in Peripheral C-Reactive Protein Levels With Canakinumab Administration is Related to Reduced Positive Symptom Severity in Patients With Schizophrenia and Inflammation
Weickert, Thomas, Jacomb, Isabella, Lenroot, Rhoshel, Lappin, Julia, Weinberg, Danielle, Brooks, William, Brown, David, Pellen, Daniel, Kindler, Jochen, Mohan, Adith, Wakefield, Denis, Lloyd, Andrew, Stanton, Clive, O'Donnell, Maryanne, Liu, Dennis, Galletly, Cherrie, Weickert, Cynthia Shannon
Published in Biological psychiatry (1969) (15.05.2019)
Published in Biological psychiatry (1969) (15.05.2019)
Get full text
Journal Article
S33. REDUCTION IN PERIPHERAL C-REACTIVE PROTEIN LEVELS WITH CANAKINUMAB ADMINISTRATION IS RELATED TO REDUCED POSITIVE SYMPTOM SEVERITY IN PATIENTS WITH SCHIZOPHRENIA AND INFLAMMATION
Weickert, Thomas, Jacomb, Isabella, Lenroot, Rhoshel, Lappin, Julia, Weinberg, Danielle, Brooks, William, Brown, David, Pellen, Daniel, Kindler, Jochen, Mohan, Adith, Wakefield, Denis, Lloyd, Andrew, Stanton, Clive, O’Donnell, Maryanne, Liu, Dennis, Galletly, Cherrie, Weickert, Cynthia Shannon
Published in Schizophrenia bulletin (09.04.2019)
Published in Schizophrenia bulletin (09.04.2019)
Get full text
Journal Article